Korea Mcnulty Co Ltd (222980) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Korea Mcnulty Co Ltd (222980) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.96 Billion ≈ $1.33 Million USD) by net assets (₩37.17 Billion ≈ $25.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Korea Mcnulty Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Korea Mcnulty Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Korea Mcnulty Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Korea Mcnulty Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Korea Mcnulty Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rma Global Ltd
AU:RMY
|
0.273x |
|
Euromedis Groupe SA
PA:ALEMG
|
0.048x |
|
MSCM Holdings Bhd
KLSE:0041
|
-0.048x |
|
Klimator AB
ST:KLIMAT
|
0.368x |
|
Weizmann Limited
NSE:WEIZMANIND
|
0.281x |
|
In8bio Inc
NASDAQ:INAB
|
-0.217x |
|
Inter-M Corporation
KQ:017250
|
0.026x |
|
Elicera Therapeutics AB
ST:ELIC
|
-0.156x |
Annual Cash Flow Conversion Efficiency for Korea Mcnulty Co Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Korea Mcnulty Co Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Korea Mcnulty Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩37.17 Billion ≈ $25.19 Million |
₩5.45 Billion ≈ $3.69 Million |
0.147x | +264.16% |
| 2024-12-31 | ₩35.16 Billion ≈ $23.83 Million |
₩-3.14 Billion ≈ $-2.13 Million |
-0.089x | -270.95% |
| 2023-12-31 | ₩37.51 Billion ≈ $25.42 Million |
₩1.96 Billion ≈ $1.33 Million |
0.052x | +156.31% |
| 2022-12-31 | ₩37.33 Billion ≈ $25.30 Million |
₩-3.46 Billion ≈ $-2.35 Million |
-0.093x | -1484.33% |
| 2021-12-31 | ₩36.70 Billion ≈ $24.87 Million |
₩246.03 Million ≈ $166.73K |
0.007x | -94.51% |
| 2020-12-31 | ₩34.46 Billion ≈ $23.35 Million |
₩4.21 Billion ≈ $2.85 Million |
0.122x | -22.95% |
| 2019-12-31 | ₩27.55 Billion ≈ $18.67 Million |
₩4.37 Billion ≈ $2.96 Million |
0.159x | +247.60% |
| 2018-12-31 | ₩27.59 Billion ≈ $18.70 Million |
₩1.26 Billion ≈ $852.86K |
0.046x | -48.21% |
| 2017-12-31 | ₩28.22 Billion ≈ $19.12 Million |
₩2.49 Billion ≈ $1.68 Million |
0.088x | -30.82% |
| 2016-12-31 | ₩27.62 Billion ≈ $18.72 Million |
₩3.52 Billion ≈ $2.38 Million |
0.127x | +31.44% |
| 2015-12-31 | ₩25.49 Billion ≈ $17.28 Million |
₩2.47 Billion ≈ $1.67 Million |
0.097x | -- |
About Korea Mcnulty Co Ltd
Mcnulty Korea Co., Ltd. produces and sells coffee beans in South Korea. The company offers whole bean/ground coffee beans, hand-drip coffee, instant coffee, and fresh and brewed coffee; and health functional food products. It also develops, produces, and sell pharmaceutical products for anti-allergic complex; and operates roastery café, as well as provides related training services. It offers its… Read more